MX374836B - Plásmido para monitorizar arginina o ai-2 en biopelículas. - Google Patents

Plásmido para monitorizar arginina o ai-2 en biopelículas.

Info

Publication number
MX374836B
MX374836B MX2016003791A MX2016003791A MX374836B MX 374836 B MX374836 B MX 374836B MX 2016003791 A MX2016003791 A MX 2016003791A MX 2016003791 A MX2016003791 A MX 2016003791A MX 374836 B MX374836 B MX 374836B
Authority
MX
Mexico
Prior art keywords
biofilms
arginine
plasmid
monitoring
environmental
Prior art date
Application number
MX2016003791A
Other languages
English (en)
Other versions
MX2016003791A (es
Inventor
Adam Underwood
Alexander Rickard
Laurence Du-Thumm
Original Assignee
Univ Michigan Regents
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52744423&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX374836(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Michigan Regents, Colgate Palmolive Co filed Critical Univ Michigan Regents
Publication of MX2016003791A publication Critical patent/MX2016003791A/es
Publication of MX374836B publication Critical patent/MX374836B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/14—Streptococcus; Staphylococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Physiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Nutrition Science (AREA)
  • Plant Pathology (AREA)

Abstract

La presente invención se refiere a composiciones y métodos para desestabilizar biopelículas, alterar la estructura 3D de biopelículas y dispersar biopelículas, para mejorar la remoción de células de la biopelícula y/o sensibilidad a otros agentes (por ejemplo, tratamientos ambientales y aplicados concurrentemente) En particular, la presente descripción se relaciona con el uso de L-arginina en la remoción y/o sensibilización (por ejemplo, a antimicrobianos) de microorganismos en aplicaciones médicas, industriales, domésticas o ambientales, así como el tratamiento de infecciones bacterianas (por ejemplo, en biopelículas).
MX2016003791A 2013-09-24 2014-09-24 Plásmido para monitorizar arginina o ai-2 en biopelículas. MX374836B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361881762P 2013-09-24 2013-09-24
US201461972920P 2014-03-31 2014-03-31
PCT/US2014/057235 WO2015048146A1 (en) 2013-09-24 2014-09-24 Compositions and method for destabilizing, altering, and dispersing biofilms

Publications (2)

Publication Number Publication Date
MX2016003791A MX2016003791A (es) 2017-01-20
MX374836B true MX374836B (es) 2025-03-06

Family

ID=52744423

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016003791A MX374836B (es) 2013-09-24 2014-09-24 Plásmido para monitorizar arginina o ai-2 en biopelículas.

Country Status (11)

Country Link
US (2) US20160235698A1 (es)
EP (3) EP3150715B1 (es)
CN (3) CN106029062A (es)
AU (6) AU2014326756B2 (es)
BR (1) BR112016006584B1 (es)
DK (1) DK3049073T3 (es)
ES (1) ES2847388T3 (es)
MX (1) MX374836B (es)
PL (1) PL3049073T3 (es)
WO (1) WO2015048146A1 (es)
ZA (1) ZA201602797B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101801521B (zh) 2007-05-14 2015-06-17 纽约州立大学研究基金会 生物膜中细菌细胞内的生理学分散响应诱导
WO2015048146A1 (en) 2013-09-24 2015-04-02 The Regents Of The University Of Michigan Compositions and method for destabilizing, altering, and dispersing biofilms
US9795579B1 (en) * 2017-04-24 2017-10-24 Knoze Jr. Corporation Oral microbiota promoting method
KR20200123146A (ko) * 2018-02-21 2020-10-28 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 이차 작용 방식을 갖는 새로운 항균제에 대한 조성물 및 방법
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
US10927397B2 (en) 2018-10-16 2021-02-23 Sterilex, Llc Compositions, devices and methods for detecting biofilms
CA3123091A1 (en) * 2018-12-26 2020-07-02 Colgate-Palmolive Company Methods of shifting biofilm in the oral cavity from pathogenic to healthy biofilm
CN119792113A (zh) * 2018-12-26 2025-04-11 高露洁-棕榄公司 使用精氨酸降低病原性细菌
MX2021007646A (es) * 2018-12-26 2021-08-11 Colgate Palmolive Co Inhibicion de la coagregacion especifica por arginina.
CA3134598A1 (en) * 2019-03-29 2020-10-08 Colgate-Palmolive Company Oral care product
CN110583697B (zh) * 2019-09-20 2021-04-06 浙江工商大学 去除铜绿假单胞菌生物膜用的高效化学生物制剂及其应用
WO2021092613A1 (en) * 2019-11-08 2021-05-14 Colgate-Palmolive Company Methods of modifying biofilm
WO2021092612A1 (en) 2019-11-08 2021-05-14 Colgate-Palmolive Company Apparatus, system, and method for testing biological samples
CN111299267B (zh) * 2020-02-12 2021-10-22 上海交通大学 一种基于群感效应的供水管网生物膜控制方法及其应用
WO2023114550A2 (en) * 2021-12-19 2023-06-22 The Trustees Of Columbia University In The City Of New York Engineering bacteria swarm patterns for spatiotemporal information encoding
CN119112857A (zh) * 2024-09-18 2024-12-13 中国科学技术大学 抑制金葡菌生物被膜形成的组合物及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0065884B1 (en) 1981-05-27 1986-08-20 Unitika Ltd. Urethral catheter capable of preventing urinary tract infection and process for producing the same
EP1159951A1 (en) * 2000-06-02 2001-12-05 Societe Des Produits Nestle S.A. Use of exogenous lactic bacteria strain against Actinomyces naeslundii-related diseases
WO2000066616A1 (en) * 1999-05-03 2000-11-09 Advanced Research & Technology Institute, Inc. METHODS AND COMPOSITIONS FOR CONTROLLING DENTAL CARIES, AND RECOMBINANT SmaA POLYPEPTIDES USEFUL FOR SAME
AU2001286741A1 (en) * 2000-08-25 2002-03-04 Trustees Of Tufts College Methods and compositions for potentiating antibiotic action against persistent/tolerant pathogenic microorganisms
US20100021942A1 (en) * 2008-07-25 2010-01-28 Paul Freemont Cell-free expression system for the detection of bacterial biofilms
WO2010075419A1 (en) * 2008-12-22 2010-07-01 Micropure, Inc Composition and method for reducing demineralization of teeth
JP5723001B2 (ja) * 2010-06-23 2015-05-27 コルゲート・パーモリブ・カンパニーＣｏｌｇａｔｅ−Ｐａｌｍｏｌｉｖｅ Ｃｏｍｐａｎｙ 治療用口腔用組成物
US20130224270A1 (en) 2010-10-27 2013-08-29 Colgate-Palmolive Company Oral Care Composition Comprising Arginine and Calcium Carbonate
US9717929B2 (en) * 2010-12-07 2017-08-01 Colgate-Palmolive Company Dentifrice compositions containing calcium silicate and a basic amino acid
AU2012332014B2 (en) * 2011-10-31 2017-01-19 Kane Biotech Inc. Compositions and methods for preventing and treating oral diseases
CN103974688A (zh) * 2011-12-15 2014-08-06 高露洁-棕榄公司 口腔护理组合物
WO2015048146A1 (en) 2013-09-24 2015-04-02 The Regents Of The University Of Michigan Compositions and method for destabilizing, altering, and dispersing biofilms

Also Published As

Publication number Publication date
ES2847388T3 (es) 2021-08-03
EP3150715B1 (en) 2018-11-14
AU2019271937B2 (en) 2021-01-28
EP3831374A1 (en) 2021-06-09
WO2015048146A1 (en) 2015-04-02
DK3049073T3 (da) 2021-02-01
AU2022271381A1 (en) 2022-12-15
CN106029062A (zh) 2016-10-12
AU2021202650A1 (en) 2021-05-27
ZA201602797B (en) 2018-12-19
EP3049073A1 (en) 2016-08-03
BR112016006584B1 (pt) 2022-11-29
EP3150715A1 (en) 2017-04-05
AU2016202002B2 (en) 2017-10-12
AU2016202002A1 (en) 2016-04-21
AU2014326756A1 (en) 2016-04-07
AU2022271381B2 (en) 2024-08-15
AU2021202650B2 (en) 2022-09-08
AU2014326756B2 (en) 2019-08-29
US20160304886A1 (en) 2016-10-20
US10570401B2 (en) 2020-02-25
US20160235698A1 (en) 2016-08-18
CN115177607A (zh) 2022-10-14
CN110129352A (zh) 2019-08-16
EP3049073A4 (en) 2017-03-15
BR112016006584A2 (pt) 2017-08-01
EP3049073B1 (en) 2020-11-04
MX2016003791A (es) 2017-01-20
AU2024264692A1 (en) 2024-12-05
PL3049073T3 (pl) 2021-10-25
AU2019271937A1 (en) 2019-12-19

Similar Documents

Publication Publication Date Title
MX374836B (es) Plásmido para monitorizar arginina o ai-2 en biopelículas.
PH12016500207A1 (en) Anti-infective compounds
UA107423C2 (en) Fluoro-pyridinone derivatives useful as antibacterial agents
EA201400838A1 (ru) ЗАМЕЩЕННЫЕ АМИДИНОМ β-ЛАКТАМЫ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В КАЧЕСТВЕ АНТИБАКТЕРИАЛЬНЫХ СРЕДСТВ
MX383908B (es) Formulaciones desinfectantes tópicas y uso de las mismas.
MX394441B (es) Una formulación a base de besifloxacina para usarse en el tratamiento del acné resistente a fármacos
BR112016007572A2 (pt) di-hidroxialquil substituído por poligalactomanano, e métodos para produzir e usar o mesmo
BR112012018021A2 (pt) antídotos anticoagulantes.
MX390762B (es) Composiciones de ciclodextrina alquilada y procesos para preparar y utilizar las mismas
ECSP13012844A (es) Composición efervescente en forma sólida para uso en aplicaciones vaginales para el tratamiento de infecciones vaginales
BR112016006366A2 (pt) uso de picolinamidas macrocíclicas como fungicidas
BR112015028853A2 (pt) Composição detergente com ph baixo
BR112016006874A2 (pt) uso de picolinamidas macrocíclicas como fungicidas
UY33754A (es) Monobactamas
CL2015003019A1 (es) Derivados biaromáticos antibacterianos
BR112015009600A2 (pt) piridina-2-amidas úteis como agonistas cb2
DOP2015000223A (es) Composiciones antimicrobianas y métodos de uso relacionados
BR112016005417A8 (pt) "compostos derivados de desoxinojirimicina, composição farmacêutica e seus usos"
UA109557C2 (uk) Похідні 2-піперазин-1-іл-4h-1,3-бензотіазин-4-ону та їх застосування для лікування інфекцій у ссавців
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
CL2017002451A1 (es) Compuestos heterocíclicos novedosos y su uso en la prevención o tratamiento de las infecciones bacterianas
BR112014030720A8 (pt) composto, composição farmacêutica e usos de inibidores de fbx03
BR112014016803A8 (pt) amidas macrocíclicas como inibidoras de protease
IN2013MU03216A (es)
BR112016006348A2 (pt) tripeptídeos anti-inflamatórios

Legal Events

Date Code Title Description
FG Grant or registration